| Application no. and date | 16777134.4 (espacenet) (Federated) (European Patent Register), 20160405 | | Patent/reg. no. and date | DK/EP 3280440, 20221116 | | Publication date | 20180214 | | Priority no. and date | US 201562143636 P, 20150406, US 201562200997 P, 20150804 | | EP pub. no. and date |
EP 3280440 20180214 | | Effective date | | | Applicant/owner | Bioverativ USA Inc., 951 Gateway Boulevard
South San Francisco, California 94080, US | | Applicant ref. no. | 1657853 | | Inventor | PANICKER, Sandip, 248 Outlook Heights Ct.
Pacifica, CA 94044, US,
PARRY, Graham, 111 W Bellevue Avenue
San Mateo, CA 94402, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , C07K 16/40 (2006.01) | | Title | HUMANISEREDE ANTI-C1S-ANTISTOFFER OG FREMGANGSMÅDER TIL ANVENDELSE DERAF | | Int. application no. | US2016026038 | | Int. publication no. | WO2016164358 | | Related patent (certificate) | | | Status | Rettet DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
